Zymeworks Inc. (ZYME)

06:47 AM

Zymeworks Launches Phase 1 Trial for ZW191 - TipRanks

06:47 AM

06:03 AM

Zymeworks Announces First Patient Dosed in Phase 1 Clinical - GlobeNewswire

06:03 AM

06:00 AM

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors - StockTitan

06:00 AM

01:22 AM

Zymeworks (NYSE:ZYME) Sets New 52-Week High Following Analyst Upgrade - Defense World

01:22 AM

Nov 04, 2024

Zymeworks stock soars to 52-week high of $14.08 amid robust gains - Investing.com Canada

Nov 04, 2024

Nov 04, 2024

Zymeworks (NYSE:ZYME) Hits New 52-Week High on Analyst Upgrade - MarketBeat

Nov 04, 2024

Nov 04, 2024

Zymeworks: Turning The Tide With 2 Key Milestones For Zanidatamab (NASDAQ:ZYME) - Seeking Alpha

Nov 04, 2024

Nov 04, 2024

Zymeworks (NYSE:ZYME) Cut to Equal Weight at Wells Fargo & Company - Defense World

Nov 04, 2024

Nov 04, 2024

Zymeworks’ (ZYME) “Neutral” Rating Reiterated at HC Wainwright - Defense World

Nov 04, 2024

Nov 03, 2024

Zymeworks Inc. (NASDAQ:ZYME) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Simply Wall St

Nov 03, 2024

Nov 03, 2024

Wells Fargo Downgrades Zymeworks (ZYME) - MSN

Nov 03, 2024

Nov 03, 2024

Zymeworks (NYSE:ZYME) Shares Gap Down – Here’s What Happened - Defense World

Nov 03, 2024

Nov 02, 2024

Zymeworks Inc. (NYSE:ZYME) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 02, 2024

Nov 02, 2024

Zymeworks Q4 2024 Earnings Preview - MSN

Nov 02, 2024

Nov 01, 2024

Zymeworks to Spotlight Innovations at Investor Conferences - MSN

Nov 01, 2024

Nov 01, 2024

Earnings call: Zymeworks reports Q3 2024 results and pipeline progress - Investing.com

Nov 01, 2024

Nov 01, 2024

Zymeworks (NYSE:ZYME) Shares Gap DownShould You Sell? - MarketBeat

Nov 01, 2024

Nov 01, 2024

Zymeworks stock downgraded at Wells Fargo (ZYME:NASDAQ) - Seeking Alpha

Nov 01, 2024

Nov 01, 2024

Time To Worry? Analysts Are Downgrading Their Zymeworks Inc. (NASDAQ:ZYME) Outlook - Simply Wall St

Nov 01, 2024

Nov 01, 2024

Zymeworks Inc. (NASDAQ:ZYME) Analysts Are Reducing Their Forecasts For Next Year - Yahoo Finance

Nov 01, 2024

Nov 01, 2024

Zymeworks Inc. (ZYME) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 01, 2024

Nov 01, 2024

Zymeworks Inc (ZYME) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo Finance

Nov 01, 2024

Nov 01, 2024

Zymeworks Reports Q3 Results and Strategic Advances - TipRanks

Nov 01, 2024

Oct 31, 2024

Zymeworks Advances Biotherapeutic Pipeline in 2024 - TipRanks

Oct 31, 2024

Oct 31, 2024

Zymeworks Provides Corporate Update and Reports Third Quarter 2024 Financial Results - GlobeNewswire

Oct 31, 2024

Oct 31, 2024

Zymeworks Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 31, 2024

Oct 31, 2024

Zymeworks Q3 2024 Earnings Preview - MSN

Oct 31, 2024

Oct 30, 2024

Zymeworks Inc (ZYME) Q3 2024 Earnings Report Preview: What To Lo - GuruFocus.com

Oct 30, 2024

Oct 30, 2024

Zymeworks (NYSE:ZYME) PT Raised to $28.00 at Stifel Nicolaus - Defense World

Oct 30, 2024

Oct 30, 2024

Assenagon Asset Management S.A. Takes Position in Zymeworks Inc. (NYSE:ZYME) - MarketBeat

Oct 30, 2024

Oct 29, 2024

Zymeworks Announces Participation in Upcoming Investor Conferences - The Korea Bizwire

Oct 29, 2024

Oct 28, 2024

Zymeworks (NYSE:ZYME) Price Target Raised to $28.00 at Stifel Nicolaus - MarketBeat

Oct 28, 2024

Oct 25, 2024

Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference - GlobeNewswire

Oct 25, 2024

Oct 24, 2024

Zymeworks (ZYME) Set to Announce Earnings on Thursday - Defense World

Oct 24, 2024

Oct 22, 2024

Zymeworks retains Neutral stock rating from Wainwright on clinical trials - Investing.com

Oct 22, 2024

Oct 22, 2024

Zymeworks retains Neutral stock rating from Wainwright on clinical trials By Investing.com - Investing.com South Africa

Oct 22, 2024

Oct 22, 2024

What Analysts Are Saying About Zymeworks Stock - Benzinga

Oct 22, 2024

Oct 22, 2024

Zymeworks doses first subject in Phase I trial of ZW171 for various forms of cancer - Clinical Trials Arena

Oct 22, 2024

Oct 21, 2024

SG Americas Securities LLC Increases Holdings in Zymeworks Inc. (NYSE:ZYME) - Defense World

Oct 21, 2024

Oct 21, 2024

Zymeworks (NYSE:ZYME) Hits New 52-Week HighShould You Buy? - MarketBeat

Oct 21, 2024

Oct 21, 2024

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers - StockTitan

Oct 21, 2024

Oct 19, 2024

Zymeworks Inc. announces board changes By Investing.com - Investing.com Nigeria

Oct 19, 2024

Oct 18, 2024

Zymeworks Inc. announces board changes - Investing.com India

Oct 18, 2024

Oct 18, 2024

Zymeworks Announces Board Changes with New Appointments - TipRanks

Oct 18, 2024

Oct 18, 2024

Zymeworks Inc. Announces Board and Committee Changes - Marketscreener.com

Oct 18, 2024

Oct 15, 2024

Zymeworks Announces Participation in Upcoming Investor Conference, Business Wires News - AsiaOne

Oct 15, 2024

Oct 15, 2024

Zymeworks (NASDAQ:ZYME) grows 6.5% this week, taking one-year gains to 89% - Simply Wall St

Oct 15, 2024

Oct 14, 2024

Zymeworks stock soars to 52-week high, hits $13.3 By Investing.com - Investing.com South Africa

Oct 14, 2024

Oct 14, 2024

Zymeworks (NYSE:ZYME) Reaches New 12-Month HighTime to Buy? - MarketBeat

Oct 14, 2024

Oct 14, 2024

Zymeworks stock soars to 52-week high, hits $13.3 - Investing.com India

Oct 14, 2024